Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$86,664
+$9,741 QoQ
Shares Held
9,200
-2.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 263 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. NVAX ranks #121 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in NVAX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,664 | 9,200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $76,923 | 9,450 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $63,504 | 9,450 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $251,430 | 29,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $292,635 | 46,450 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $335,884 | 52,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $421,296 | 52,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $567,087 | 44,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $568,434 | 44,900 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $208,408 | 43,600 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $219,840 | 45,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $323,266 | 44,650 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $1,261,897 | 69,335 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,651,730 | 51,560 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,300,993 | 44,820 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,206,258 | 29,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,448,601 | 16,635 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,208,873 | 10,404 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,632,515 | 9,004 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,679,898 | 15,065 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,673,243 | 43,131 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||